2 Patents
- US123502462025Eflornithine and Sulindac, Fixed Dose Combination Formulation
Cancer Prevention Pharmaceuticals, Inc.
0 cites - US119256132024Eflornithine and Sulindac, Fixed Dose Combination Formulation
Cancer Prevention Pharmaceuticals, Inc.
0 cites